EN DE
STOCK COMPARISON

Lepu Medical Tech Beijing vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Lepu Medical Tech Beijing (300003) and Abbott Laboratories (ABT) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Lepu Medical Tech Beijing as the less overvalued of the two: Lepu Medical Tech Beijing trades at ¥13.14 versus a fair value of ¥11.48 (-13%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).
Lepu Medical Tech Beijing
300003.SHE · CNY · Health Care
-13%
upside to fair value
overvalued
Price¥13.14
Fair Value¥11.48
Quality65/100
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$108
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Lepu Medical Tech BeijingAbbott Laboratories
Valuation
26.2×P/E (TTM)27.7×
3.39×P/S (TTM)3.89×
1.35×P/B3.36×
15.6×EV/EBITDA15.1×
2.05×PEG1.47×
2.7%Dividend yield—
¥0.33Dividend per share—
Profitability
13%Net margin14%
24%Operating margin13%
5%Return on equity12%
3%Return on assets6%
Growth
-4%Revenue growth (YoY)8%
-15.1%Avg. growth/yr (3Y)0.5%
-4.2%Avg. growth/yr (5Y)5.1%
Balance & size
0.18×Debt / equity0.19×
$3BMarket cap$175B
weakGrowth qualityhealthy

Abbott Laboratories leads: 5 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Lepu Medical Tech Beijingof which business quality 63 · market factors 29 Abbott Laboratoriesof which business quality 66 · market factors 51
ProfitabilityMargins and returns on capital today
34
50
Quality GrowthAre margins and returns improving?
53
47
CashflowEarnings quality: real cash, not paper profit
63
71
Fin. StrengthBalance sheet, leverage, solvency risk
77
80
InvestmentDisciplined investing over empire-building
78
65
Low VolatilityCalm price path (market factor)
67
83
MomentumPrice trend over the last 3–12 months (market factor)
10
40
52W MomentumDistance to the 52-week high (market factor)
17
33
Net IssuanceBuybacks instead of dilution
81
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Lepu Medical Tech Beijing

DCF Models¥14.73
Earnings-Based¥8.45
Dividend Discount¥6.51
Multiples¥11.43
Asset-Based¥5.86
Growth DCF¥13.51
Economic Profit¥8.49
Growth Earnings¥11.51

14 of 26 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Lepu Medical Tech Beijing
Bear ¥8.61Fair Value ¥11.48Bull ¥14.35
¥13.14 = current price (white tick)
Abbott Laboratories
Bear $51.84Fair Value $74.79Bull $94.43
$108 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Lepu Medical Tech Beijing · Health Care

Quality score65 · Top 25%
Fair value upside-13% · above median

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-31% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Lepu Medical Tech Beijing as the less overvalued of the two: Lepu Medical Tech Beijing trades at ¥13.14 versus a fair value of ¥11.48 (-13%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →
Lepu Medical Tech Beijing · Abbott Laboratories

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Lepu Medical Tech Beijing

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Abbott Laboratories

UnitedHealth Group vs Abbott LaboratoriesUnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs Amgen
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.